# A Randomized, Controlled, Open-Label, Multi-center Clinical Study Comparing the Efficacy of Close Follow-Up Versus Adjuvant Chemotherapy in Patients With Stage IB-IIA Gastric or Gastroesophageal Junction Adenocarcinoma Following Radical Surgery

> **NCT07751302** · NA · RECRUITING · sponsor: **Xijing Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Stage IB-IIA Adenocarcinoma of the Stomach or Gastroesophageal Junction

## Interventions

- **DRUG:** Tegafur Gimeracil Oteracil Potassium Capsules for oral administration

## Key facts

- **NCT ID:** NCT07751302
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-10
- **Primary completion:** 2036-01-31
- **Final completion:** 2036-01-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751302, "A Randomized, Controlled, Open-Label, Multi-center Clinical Study Comparing the Efficacy of Close Follow-Up Versus Adjuvant Chemotherapy in Patients With Stage IB-IIA Gastric or Gastroesophageal Junction Adenocarcinoma Following Radical Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07751302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*